-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The Group’s new Jiangsu Bosheng product—the multi-layer co-extruded biofilm for single-use fluid preparation systems—has been put into industrial production and is now available for sale.
Category:
Time：2021-05-31
Recently, Jiangsu Bosheng Medical New Materials Co., Ltd., a wholly-owned subsidiary of Shisi Pharmaceutical Group, has launched into industrial production and begun selling its new product—the multi-layer co-extruded biofilm for single-use infusion systems—which is currently the only domestic manufacturer capable of replacing imported biofilms.
It is reported that this product meets the requirements of USP Class VI and relevant national standards, and is widely used in the research and development and production of vaccines and biological drugs, boasting promising market prospects.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code